Accord Urges Justices To Reject 'Crush-Resistant' Oxy IP Row

Accord Healthcare Inc. says the U.S. Supreme Court should reject bankrupt OxyContin maker Purdue Pharma LP's attempt to revive its legal effort to use patent laws to block the release of...

Already a subscriber? Click here to view full article